2021
DOI: 10.2196/26004
|View full text |Cite
|
Sign up to set email alerts
|

Developing Digital Tools for Remote Clinical Research: How to Evaluate the Validity and Practicality of Active Assessments in Field Settings

Abstract: The ability of remote research tools to collect granular, high-frequency data on symptoms and digital biomarkers is an important strength because it circumvents many limitations of traditional clinical trials and improves the ability to capture clinically relevant data. This approach allows researchers to capture more robust baselines and derive novel phenotypes for improved precision in diagnosis and accuracy in outcomes. The process for developing these tools however is complex because data need to be collec… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
9
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 97 publications
0
9
0
Order By: Relevance
“…Using smartphones for health research can also help achieve operational efficiency by relying less on traditional research facilities or intermediaries for data collection, which require in-person contact between the study participants and the research team [ 6 , 19 , 20 ]. Researchers can communicate asynchronously and synchronously with participants and assess their health by actively and passively collecting individualized real-world data [ 4 , 21 , 22 ]. Active data are defined as data generated through effortful participation (eg, completing a survey).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Using smartphones for health research can also help achieve operational efficiency by relying less on traditional research facilities or intermediaries for data collection, which require in-person contact between the study participants and the research team [ 6 , 19 , 20 ]. Researchers can communicate asynchronously and synchronously with participants and assess their health by actively and passively collecting individualized real-world data [ 4 , 21 , 22 ]. Active data are defined as data generated through effortful participation (eg, completing a survey).…”
Section: Introductionmentioning
confidence: 99%
“…However, despite the promise of decentralized health research, several challenges related to the representation and inclusiveness of recruitment and the retention of target populations have surfaced [ 21 , 24 , 25 ], resulting in sparse, unbalanced, and nonrepresentative real-world data collection [ 21 ]. Typically, decentralized studies recruit from various web-based sources such as social media (Facebook [ 26 ] and Reddit [ 27 ]), crowdsourced platforms (Prolific [ 28 ]; Amazon Mechanical Turk, MTurk [ 29 ]; Centiment [ 30 ]; and CloudResearch [ 31 ]), and partnerships with patient registries or advocacy groups [ 32 , 33 ].…”
Section: Introductionmentioning
confidence: 99%
“…Although remote digital assessments are not new, the COVID-19 pandemic accelerated the need to adopt remote or hybrid clinical assessment or research methods [ 19 , 20 ]. Alongside advances in technology and connectivity, this has led to a growing interest in the use of personal digital devices to collect clinically informative data.…”
Section: Introductionmentioning
confidence: 99%
“…Remote data collection tools range from online platforms and custom apps for self-reporting outcomes to wearables that continuously collect physiological measurements [ 4 ]. Such observations can be collected at high frequencies, increasing the granularity of data to improve the capture of clinically relevant outcomes in ecologically valid settings, compared to traditional clinical studies that typically involve less frequent observations collected during in-person study visits [ 9 , 10 ]. Ultimately, continuously worn wearable data sources may enable digital biomarkers and predictive models that translate detailed data into trial endpoints, clinically actionable insights, and effective diagnoses [ 11 - 13 ].…”
Section: Introductionmentioning
confidence: 99%